Status:
COMPLETED
Selective Thromboembolism Prophylaxis After Arthroplasty
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Venous Thrombosis, Deep
Arthroplasty Complications
Eligibility:
All Genders
Phase:
NA
Brief Summary
Asian populations have a lower rate of high-risk gene mutations of venous thrombosis, which means a reasonable perioperative anticoagulant management after hip or knee arthroplasty for Caucasian popul...
Detailed Description
Asian patients who underwent hip or knee arthroplasty in Guangdong General Hospital from August 2016 to August 2017 were randomly divided into selective anticoagulation group (SAG) and conventional an...
Eligibility Criteria
Inclusion
- over 18 years of age,
- ASA Ⅰ-Ⅱ grade,
- BMI \<40Kg / M \^ 2
- Underwent total knee arthroplasty/ total hip arthroplasty in Guangdong General Hospital
- consent to enroll in this study
Exclusion
- history of VTE, preoperative infection, preoperative coagulation
- liver and kidney function existed clinically abnormalities
- history of tumor
- history of vascular surgery
- heart infarction or cerebral infarction within 6 months
- history of lower extremity surgery within 3 months
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
197 Patients enrolled
Trial Details
Trial ID
NCT03804697
Start Date
August 1 2016
End Date
January 1 2018
Last Update
January 15 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.